HOME >> BIOLOGY >> NEWS
Top biomedical researchers form Editorial Directorate for open-access publishing venture

Some of the world's leading biological and medical scientists have joined the Editorial Directorate of BioMed Central, a new publishing house that will give free on-line access to biomedical research. BioMed Central will allow researchers around the world to access peer-reviewed research articles free-of-charge, and without the traditional barriers to access imposed by conventional publishers. The BioMed Central Directorate includes:

PROFESSOR ELIZABETH H. BLACKBURN
Professor of Biochemistry and Biophysics and Professor of Microbiology and Immunology at the University of California, San Francisco (USA)

DR STEVEN E. HYMAN
Director of the National Institute of Mental Health (USA)

PROFESSOR MARC W. KIRSCHNER
Head of the Department of Cell Biology at Harvard Medical School. (USA)

PROFESSOR PHILIPPE KOURILSKY
Professor of the Collège de France and Director General of the Pasteur Institute (France)

PROFESSOR JOSEPH BOYD MARTIN
Dean of the Faculty of Medicine at Harvard Medical School (USA)

DR DAVID G. NATHAN
President of the Dana-Farber Cancer Institute (USA)

DR PAUL NURSE
Director-General of the Imperial Cancer Research Fund (UK).

DR HAROLD E. VARMUS
President of the Memorial Sloan-Kettering Cancer Center (USA)

PROFESSOR SIR DAVID WEATHERALL
Regius Professor of Medicine at the University of Oxford (UK)

PROFESSOR MITSUHIRO YANAGIDA
Professor of Kyoto University, Graduate School of Biostudies (Japan)

"BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime", says Dr Paul Nurse.

"BioMed Central and other on-line initiatives will serve to make science more democratic, and more efficient, and in so doing will speed scientific progress," says Dr Steven Hyman. "In the long run, I think that journals that are not freely available in electronic formats will be read less and less".

"BioMed Central promises to d
'"/>

Contact: Andrew McLaughlin
andrew@biomedcentral.com
44-20-7323-0323
BioMed Central
21-May-2000


Page: 1 2 3

Related biology news :

1. Illustrated guidebook published for Chinese biomedical scientists and students
2. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
3. Ottawas leadership in biomedical and health research has paid off
4. New world record magnet for chemical and biomedical research
5. Telescience recognized for facilitating biomedical research on a global network
6. Digital Biology Week: Building a national infrastructure for biomedical computing
7. New grants enable biomedical research centers to share science with their communities
8. Dr. Robert Langer, distinguished leader in the field of biomedical engineering, to lecture at NIH
9. UW-Madison scientists return to rat as biomedical research tool
10. Stanford biomedical ethicist speaks on role of race in scientific research
11. University of New Hampshire launches biomedical research network with $5.6 million grant

Post Your Comments:
(Date:4/1/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces the second shipment ... underway to early access pre-order customers. ... retail outlets including Walmart, Target, AT&T, Dunkin, Donuts, Stop ... accepted at all outlets and very easy to use. ...
(Date:3/26/2015)... -- The Granite Club, Canada,s ... today announced it has implemented a state-of-the-art access and ... members and staff, while restricting access to authorized users ... FST,s IMID Access system because it has the perfect ... staff, in addition to unparalleled security," said James ...
(Date:3/23/2015)... Mass , March 23, 2015 SoundView Technology ... of NXT-ID,s (NASDAQ: NXTD ) Wocket smart wallet. SoundView was ... user feedback on their experience with the Wocket in multiple ... at CVS, Whole Foods and other retailers, making both debit ... Kris Tuttle also says, "If the company meets their ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4
(Date:4/16/2015)... April 16, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... U.S. joint venture with G-treeBNT (ReGenTree LLC) has ... clinical trial for the orphan disorder, neurotrophic keratopathy ... dry eye syndrome (DES) in the U.S.  Both ... RGN-259/GBT201, this year.  Each of these eye disorders ...
(Date:4/16/2015)... 16, 2015  AnaptysBio, Inc., a leader in ... today announced the advancement of its first-in-class ... studies. The Company,s anti-IL-36R therapeutic antibody, called ... pustular psoriasis (GPP), an orphan systemic inflammatory ... wholly owned within AnaptysBio,s proprietary antibody pipeline ...
(Date:4/16/2015)... Switzerland , April 16, 2015 ... of Debiopharm Group ™ , a Swiss-based global ... unmet medical needs as well as companion ... the investigational compounds Debio 1143 (SMAC mimetic) and ... at the 2015 Annual meeting of the ...
(Date:4/16/2015)... Washington (PRWEB) April 16, 2015 ... Applied Cancer Science and Resolution Bioscience, Inc. today ... to co-develop a novel, blood-based, clinic ready, Next ... cancer (NSCLC). The collaboration is the first to ... RET, and ROS1 fusions in blinded plasma samples ...
Breaking Biology Technology:RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer 2Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer 3
Cached News: